ArticleHuman vaccines & immunotherapeutics2020

A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B.

Allan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.